AU2003277891A1 - Hcv ns-3 serine protease inhibitors - Google Patents

Hcv ns-3 serine protease inhibitors

Info

Publication number
AU2003277891A1
AU2003277891A1 AU2003277891A AU2003277891A AU2003277891A1 AU 2003277891 A1 AU2003277891 A1 AU 2003277891A1 AU 2003277891 A AU2003277891 A AU 2003277891A AU 2003277891 A AU2003277891 A AU 2003277891A AU 2003277891 A1 AU2003277891 A1 AU 2003277891A1
Authority
AU
Australia
Prior art keywords
hcv
protease inhibitors
serine protease
serine
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003277891A
Inventor
Karin Oscarsson
Bertil Samuelsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medivir AB
Original Assignee
Medivir AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medivir AB filed Critical Medivir AB
Publication of AU2003277891A1 publication Critical patent/AU2003277891A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003277891A 2002-09-23 2003-09-23 Hcv ns-3 serine protease inhibitors Abandoned AU2003277891A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02021111 2002-09-23
EP02021111.6 2002-09-23
PCT/EP2003/010595 WO2004026896A2 (en) 2002-09-23 2003-09-23 Hcv ns-3 serine protease inhibitors

Publications (1)

Publication Number Publication Date
AU2003277891A1 true AU2003277891A1 (en) 2004-04-08

Family

ID=32010923

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003277891A Abandoned AU2003277891A1 (en) 2002-09-23 2003-09-23 Hcv ns-3 serine protease inhibitors

Country Status (2)

Country Link
AU (1) AU2003277891A1 (en)
WO (1) WO2004026896A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101159575B1 (en) 2004-01-30 2012-07-06 얀센 알 앤드 디 아일랜드 Hcv ns-3 serine protease inhibitors
PE20070211A1 (en) 2005-07-29 2007-05-12 Medivir Ab MACROCYCLIC COMPOUNDS AS INHIBITORS OF HEPATITIS C VIRUS
AR055395A1 (en) 2005-08-26 2007-08-22 Vertex Pharma INHIBITING COMPOUNDS OF THE ACTIVITY OF SERINA PROTEASA NS3-NS4A OF HEPATITIS C VIRUS
BRPI0720306A2 (en) 2006-12-14 2014-02-04 Aileron Therapeutics Inc BIS-SUFIDRIL MACROCYCLING SYSTEMS
US8889632B2 (en) 2007-01-31 2014-11-18 Dana-Farber Cancer Institute, Inc. Stabilized p53 peptides and uses thereof
KR101623985B1 (en) 2007-03-28 2016-05-25 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 Stitched polypeptides
WO2010083347A2 (en) 2009-01-14 2010-07-22 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
JP2013535514A (en) 2010-08-13 2013-09-12 エイルロン セラピューティクス，インコーポレイテッド Peptidomimetic macrocycle
JP6342808B2 (en) 2011-10-18 2018-06-13 エイルロン セラピューティクス，インコーポレイテッド Peptidomimetic macrocycle
BR112014020103A2 (en) 2012-02-15 2018-10-09 Aileron Therapeutics, Inc. peptidomimetic macrocycles
AU2013221433B2 (en) 2012-02-15 2018-01-18 Aileron Therapeutics, Inc. Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
BR112015009470A2 (en) 2012-11-01 2019-12-17 Aileron Therapeutics Inc disubstituted amino acids and their methods of preparation and use
SG11201702223UA (en) 2014-09-24 2017-04-27 Aileron Therapeutics Inc Peptidomimetic macrocycles and uses thereof
CN107106642B (en) 2014-09-24 2021-02-26 艾瑞朗医疗公司 Peptidomimetic macrocycles and formulations thereof
CA2979847A1 (en) 2015-03-20 2016-09-29 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
US10059741B2 (en) 2015-07-01 2018-08-28 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
US10023613B2 (en) 2015-09-10 2018-07-17 Aileron Therapeutics, Inc. Peptidomimetic macrocycles as modulators of MCL-1

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9712544B1 (en) * 1996-10-18 2013-10-22 SERINE PROTEASE INHIBITORS, PHARMACEUTICAL COMPOSITION UNDERSTANDING THE SAME AND ITS USES
AR029851A1 (en) * 2000-07-21 2003-07-16 Dendreon Corp NEW PEPTIDES AS INHIBITORS OF NS3-SERINA PROTEASA DEL VIRUS DE HEPATITIS C
SV2003000617A (en) * 2000-08-31 2003-01-13 Lilly Co Eli INHIBITORS OF PROTEASA PEPTIDOMIMETICA REF. X-14912M

Also Published As

Publication number Publication date
WO2004026896A3 (en) 2005-01-13
WO2004026896A2 (en) 2004-04-01

Similar Documents

Publication Publication Date Title
TWI367211B (en) Hcv ns-3 serine protease inhibitors
HK1081196A1 (en) Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
HK1090644A1 (en) Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
HK1098164A1 (en) Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
EP1590442A3 (en) Macrocyclic hepatitis c serine protease inhibitors
HK1095594A1 (en) 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives as inhibitors of serine proteases, particularly hcv ns3-ns4a protease
PL375486A1 (en) Potent inhibitor of hcv serine protease
AU2002305926A1 (en) Cysteine protease inhibitors
AU2003277891A1 (en) Hcv ns-3 serine protease inhibitors
AU2003234630A1 (en) Cysteine protease inhibitors
AU2003256305A1 (en) Peptidic compounds as cysteine protease inhibitors
AU2003269984A1 (en) Protease inhibitors
AU2003247776A1 (en) Serine protease 16
AU2002342682A1 (en) Protease inhibitors
AU2003263738A1 (en) Protease inhibitors
AU2003292406A1 (en) Serine protease
AU2003252734A1 (en) Novel serine protease
AU2002325108A1 (en) Serine protease inhibitor and processes for the preparation thereof
AU2002363791A1 (en) Protease enzyme inhibitors
AU2003287325A1 (en) N-cycloalkylglycines as hiv protease inhibitors
AU2003233642A1 (en) Protease inhibitors
AU2003304496A1 (en) Protease inhibitors
AU2003252417A1 (en) Protease inhibitor
AU2003269878A1 (en) Protease inhibitors
AU2002311768A1 (en) Aminopyrrolidine sulfonamides as serine protease inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase